BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22579373)

  • 1. In regard to Zhou et al "Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis" (Int J Radiat Oncol Biol Phys 2012;82:e359-e365).
    Ozyar E; Caglar HB; Atalar B
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):482-3. PubMed ID: 22579373
    [No Abstract]   [Full Text] [Related]  

  • 2. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.
    Zhou GQ; Tang LL; Mao YP; Chen L; Li WF; Sun Y; Liu LZ; Li L; Lin AH; Ma J
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e359-65. PubMed ID: 22000748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In regard to MarciĆ© et al.: in vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy (Int J Radiat Oncol Biol Phys 2005;61:1603-1606).
    Ayyangar K; Nehru R; Djajaputra D; Zhen W; Enke C
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):310-1; author reply 311. PubMed ID: 16111605
    [No Abstract]   [Full Text] [Related]  

  • 4. In regard to Laskar et al.: Nasopharyngeal carcinoma in children: ten years' experience at the Tata Memorial Hospital, Mumbai (Int J Radiat Oncol Biol Phys 2004;58:189-195).
    Onal C; Ozyar E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):686; author reply 686. PubMed ID: 15380607
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy: In regard to Lee et al. (Int J Radiat Oncol Biol Phys 2006;64:301-320).
    Dai J; Hu Y
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1594-5. PubMed ID: 16863939
    [No Abstract]   [Full Text] [Related]  

  • 6. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer: in regard to Schoenfeld et al. (Int J Radiat Oncol Biol Phys 2008;71:377-385).
    Studer GM; Glanzmann C
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1271-2; author reply 1272. PubMed ID: 18954722
    [No Abstract]   [Full Text] [Related]  

  • 7. Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
    Ost P; Fonteyne V; De Neve W; De Gersem W; De Wagter C; Vandecasteele K; Duprez F; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286; author reply 1287. PubMed ID: 19251105
    [No Abstract]   [Full Text] [Related]  

  • 8. Does sacrificing the deep lobe of parotid gland prevent marginal miss? In regard to Chen et al. (Int J Radiat Oncol Biol Phys 2011;80:1423-1429).
    Yazici G; Cengiz M; Yildiz F; Ozyigit G
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1321-2; author reply 1322. PubMed ID: 22385719
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with image-guided radiotherapy in an accelerated partial breast intensity-modulated radiotherapy protocol: in regard to Leonard CE et al. (Int J Radiat Oncol Biol Phys Epub May 19, 2009).
    Gierga DP; Taghian AG; Chen GT
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):315; author reply 315. PubMed ID: 20005463
    [No Abstract]   [Full Text] [Related]  

  • 10. In regard to Hoppe et al. (Int J Radiat Oncol Biol Phys 2008;72:1283-1286).
    Lo SS; Fakiris AJ; Wang JZ; Mayr NA
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):977; author reply 978. PubMed ID: 19480981
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma: in regard to Allen et al. (Int J Radiat Oncol Biol Phys 2006;65:640-645).
    Komaki R; Liao Z; Liu H; Tucker S; Rice D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1595-6; author reply 1596. PubMed ID: 17126220
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased risk of ischemic stroke in young nasopharyngeal carcinoma patients. in regard to Lee et al. (Int J Radiat Oncol Biol Phys 2011;81:e833-e838).
    Bahl A; Ghoshal S; Sharma SC
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1321; author reply 1321. PubMed ID: 22385718
    [No Abstract]   [Full Text] [Related]  

  • 13. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?: in regard to Macmillan MS et al. (Int J Radiat Oncol Biol Phys 2010;77:1397-1402).
    Puri A
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1591; author reply 1591. PubMed ID: 21030161
    [No Abstract]   [Full Text] [Related]  

  • 14. In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453).
    Albertini F; Lomax AJ; Hug EB
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1333-4; author reply 1334-5. PubMed ID: 17967323
    [No Abstract]   [Full Text] [Related]  

  • 15. In regards to Sze et al.: Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control (Int J Radiat Oncol Biol Phys 2004;59:21-27).
    Onal C; Ozyar E
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):629; author reply 629. PubMed ID: 15667986
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation" Int J Radiat Oncol Biol Phys 2009;75:1290-1296).
    Wolmark N; Curran WJ; Vicini F; White J; Costantino JP; Arthur D; Kuske R; Rabinovitch R; Julian TB; Parda DS
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):317; author reply 318. PubMed ID: 20394863
    [No Abstract]   [Full Text] [Related]  

  • 17. Calculated risk of fatal secondary malignancies from intensity-modulated radiotherapy: In regard to Kry et al. (Int J Radiat Oncol Biol Phys 2005;62:1195-1203).
    Schneider U
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1290; author reply 1290-1. PubMed ID: 16504771
    [No Abstract]   [Full Text] [Related]  

  • 18. Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy: in regard to Gondi v, et al. (Int j radiat oncol biol phys 2010;78:1244-1252).
    Knisely JP; Yu JB
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):957-8; author reply 958. PubMed ID: 21281899
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical setup and appropriate parameters are essential for plan comparison: in regards to Ringash et al. (Int J Radiat Oncol Biol Phys 2005;63:732-738).
    Chia-Hsien Cheng J
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):311; author reply 311-2. PubMed ID: 16618587
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
    Russi EG; Pergolizzi S; Lucio F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.